Abbott Laboratories (ABT): Poised For Long-Term Success?

Andrew Cummings
October 20, 2017

A P/B ratio of less than 1.0 can indicate that a stock is undervalued, while a ratio of greater than 1.0 may indicate that a stock is overvalued. On average, analysts expect that Abbott Laboratories will post $2.50 earnings per share for the current year. The ex-dividend date will be Wednesday the 12th of July 2017. It has underperformed by 47.68% the S&P500. Days to cover decreased from 5.0 to 3.0 and the percentage of shorted shares is 0.01% as of August 31. Its down 0.75, from 1.63 in 2017Q1. 102 funds opened positions while 441 raised stakes. During the last 52 weeks, the (NYSE:ABT) price has been as high as $56.6 and as low as $37.38. Glynn Management Ltd Liability holds 25,000 shares.

Abbott Laboratories (NYSE:ABT) ended its day at $55.77 with the rising stream of 1.29% and its total traded volume was 9.04 million shares more than the average volume. Cincinnati Fincl has invested 0.55% in Abbott Laboratories (NYSE:ABT). Bridges Investment Counsel holds 0.65% or 58,792 shares. A statistical measure of the dispersion of returns (volatility) for ABT producing salvation in Investors mouth, it has week volatility of 1.18% and for the month booked as 1.33%. Korea Invest has invested 0.16% in Abbott Laboratories (NYSE:ABT). 96,519 were reported by Novare Lc. Moreover, Asset has 0.01% invested in United Bankshares, Inc. Reilly Fincl Ltd accumulated 219,744 shares. Deutsche Commercial Bank Ag has invested 0.1% in Abbott Laboratories (NYSE:ABT).

Since June 15, 2017, it had 0 insider purchases, and 1 insider sale for $26,482 activity. Through this figure traders can analyze that ABT show whether or not a stock now most active and standing in buying side or sell side. Therefore 58% are positive. The firm has "Buy" rating by Edward Jones given on Tuesday, June 21. As per Monday, August 10, the company rating was reinitiated by Credit Suisse. Seven investment analysts have rated the stock with a hold rating and ten have assigned a buy rating to the stock. On Friday, September 22 the stock rating was maintained by Stifel Nicolaus with "Buy". The firm earned "Buy" rating on Friday, June 16 by Jefferies. The company was maintained on Monday, October 2 by RBC Capital Markets. RBC Capital Markets maintained UnitedHealth Group Inc (NYSE:UNH) on Monday, August 21 with "Buy" rating. Goldman Sachs downgraded the shares of ABT in report on Friday, November 13 to "Neutral" rating. BMO Capital Markets maintained Abbott Laboratories (NYSE:ABT) on Thursday, July 20 with "Hold" rating. It also reduced International Business Machs (NYSE:IBM) stake by 3,177 shares and now owns 6,342 shares. Armada Hoffler Pptys Inc (NYSE:AHH) was raised too. Barclays Capital has "Overweight" rating and $52 target. Covington Mgmt stated it has 194,358 shares or 0.76% of all its holdings.

Analyst Thoughts About Axcelis Technologies, Inc. "We've seen a stabilizing of China; it hasn't been as choppy as it was in the last 2 years", Chief Executive Miles White said. GCAP's profit will be $7.09M for 10.20 P/E if the $0.15 EPS becomes a reality.

Looking forward, the company's quarterly earnings are expected to come at $0.65 in the three months through September 2017 and $0.73 in the quarter ending December 2017, reflecting 10.17% and 12.31% growth, respectively.

Investors sentiment increased to 2.33 in Q2 2017. Its up 0.04, from 0.98 in 2017Q1. Northeast Financial Consultants Inc invested in 0.08% or 4,232 shares. 3,834 are owned by Jaffetilchin Inv Prtnrs Ltd Liability Corp.

General Motors Company (NYSE:GM) gained 0.22% with the closing price of $45.12. Cordasco Ntwk invested in 0.3% or 5,516 shares. Public Employees Retirement Association Of Colorado, Colorado-based fund reported 177,070 shares. Cove Street Ltd Liability Corp stated it has 267,781 shares or 0.2% of all its holdings.

Chief Financial Officer Brian Yoor said he expects the recently closed Alere deal to contribute around $475 million to reported sales this year. Alliancebernstein LP reported 0% in Gain Capital Holdings Inc (NYSE:GCAP). Holt Capital Advisors Lc Dba Holt Capital Prns Limited Partnership invested in 0.34% or 20,581 shares. Letko Brosseau & Assocs reported 0.23% of its portfolio in PepsiCo, Inc. Bnp Paribas Arbitrage holds 50,727 shares or 0.01% of its portfolio. (NYSE:PEP). Veritas Invest (Uk) reported 0.15% of its portfolio in PepsiCo, Inc. The stock was sold at an average price of $50.00, for a total value of $750,000.00.

Other reports by iNewsToday